Clinical Trial Update: The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating whether niacin affects oxidative stress in patients with hypercholesterolemia; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Hypercholesterolemia | Phase 3 | Status: UNKNOWN